The management of autoimmunity in patients with cholestatic liver diseases

Ahmad H. Ali, Elizabeth J. Carey, Keith D. Lindor

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations


Cholestatic liver diseases are rare diseases that often lead to cirrhosis and its consequent complications. In addition to liver-related morbidity, patients with cholestatic liver diseases often suffer from autoimmune diseases that affect several organs and tissues. The robust and efficient data collection and collaboration between hepatologists and rheumatologists have led to significant advancements in understanding the relationship between the cholestatic liver diseases and associated autoimmune diseases. In this paper, we discuss the cholestatic liver diseases (primary biliary cirrhosis, primary sclerosing cholangitis and immunoglobulin G4 associated cholangitis) and associated autoimmune diseases.

Original languageEnglish (US)
Pages (from-to)73-91
Number of pages19
JournalExpert Review of Gastroenterology and Hepatology
Issue number1
StatePublished - Jan 1 2016


  • Antimitochondrial antibody
  • Autoimmune
  • IgG4-associated cholangitis
  • Primary biliary cirrhosis
  • Primary sclerosing cholangitis

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology


Dive into the research topics of 'The management of autoimmunity in patients with cholestatic liver diseases'. Together they form a unique fingerprint.

Cite this